ZA807513B - N-admantane-substituted tetra-peptide amides - Google Patents

N-admantane-substituted tetra-peptide amides

Info

Publication number
ZA807513B
ZA807513B ZA00807513A ZA807513A ZA807513B ZA 807513 B ZA807513 B ZA 807513B ZA 00807513 A ZA00807513 A ZA 00807513A ZA 807513 A ZA807513 A ZA 807513A ZA 807513 B ZA807513 B ZA 807513B
Authority
ZA
South Africa
Prior art keywords
admantane
peptide amides
substituted tetra
tetra
substituted
Prior art date
Application number
ZA00807513A
Other languages
English (en)
Inventor
R Mazur
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA807513B publication Critical patent/ZA807513B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA00807513A 1979-12-03 1980-12-02 N-admantane-substituted tetra-peptide amides ZA807513B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/099,765 US4273704A (en) 1979-12-03 1979-12-03 N-Adamantane-substituted tetrapeptide amides

Publications (1)

Publication Number Publication Date
ZA807513B true ZA807513B (en) 1982-07-28

Family

ID=22276513

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807513A ZA807513B (en) 1979-12-03 1980-12-02 N-admantane-substituted tetra-peptide amides

Country Status (16)

Country Link
US (1) US4273704A (pt)
JP (1) JPS5692847A (pt)
AU (1) AU6499080A (pt)
BE (1) BE886472A (pt)
CA (1) CA1151642A (pt)
DE (1) DE3044793A1 (pt)
DK (1) DK513480A (pt)
ES (2) ES8205753A1 (pt)
FR (1) FR2476073A1 (pt)
GB (1) GB2066262B (pt)
IT (1) IT1127930B (pt)
NL (1) NL8006586A (pt)
NO (1) NO803640L (pt)
PT (1) PT72141B (pt)
SE (1) SE8008428L (pt)
ZA (1) ZA807513B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404135A (en) * 1981-07-20 1983-09-13 G. D. Searle & Co. Enkephalin derivatives
US4407746A (en) * 1981-12-14 1983-10-04 G. D. Searle & Co. Cyclohexyl and phenyl substituted enkephalins
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide
US4629784A (en) * 1983-08-16 1986-12-16 The University Of Georgia Research Foundation, Inc. Synthesis of cyclopropane amino acids
DE3485587D1 (de) * 1983-08-16 1992-04-23 Univ Georgia Res Found Herstellung von aminocyclopropancarbonsaeuren und von peptiden.
US4510085A (en) * 1984-04-12 1985-04-09 G.D. Searle & Co. Antihypertensive tetrapeptide amides
US4514332A (en) * 1984-04-16 1985-04-30 G. D. Searle & Co. Tetrapeptide adamantyl amides
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
US4822775A (en) * 1986-02-14 1989-04-18 G. D. Searle & Co. Phenyl substituted dipeptide amides
US4880829A (en) * 1985-08-14 1989-11-14 G. D. Searle And Company Substituted dipeptide amides #3
US4758675A (en) * 1986-07-14 1988-07-19 G. D. Searle & Co. 3-thiophene-substituted tyrosyl dipeptide amides
EP0668290B1 (en) * 1990-02-28 1998-11-11 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
US5652335A (en) * 1990-02-28 1997-07-29 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
US6468487B1 (en) 1997-01-14 2002-10-22 Daicel Chemical Industries, Ltd. Nitration or carboxylation catalysts
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
US7880001B2 (en) * 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US20050261302A1 (en) * 2004-04-29 2005-11-24 Hoff Ethan D Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
US8415354B2 (en) * 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20100222316A1 (en) 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20050245534A1 (en) * 2004-04-29 2005-11-03 Link James T Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US20080275112A1 (en) * 2004-07-23 2008-11-06 Schreiner Peter R Invention Concerning Aminoadamantane Compounds
EP1812407A2 (en) * 2004-11-02 2007-08-01 Pfizer, Inc. Novel compounds of substituted and unsubstituted adamantyl amides
US8198331B2 (en) * 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
JP5078621B2 (ja) 2005-01-05 2012-11-21 アボット・ラボラトリーズ １１−β−ヒドロキシステロイドデヒドロゲナーゼ１型酵素の阻害薬としてのアダマンチル誘導体
HRP20050242B1 (en) * 2005-03-15 2010-09-30 Institut Ruđer Bošković Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
JP5736098B2 (ja) * 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
EP2399926A1 (en) * 2010-06-22 2011-12-28 Justus-Liebig-Universität Giessen Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents
CN112552374B (zh) * 2019-09-10 2024-06-04 西藏海思科制药有限公司 一种肽酰胺类化合物及其中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732451A1 (de) * 1976-07-27 1978-02-02 Reckitt & Colmann Prod Ltd Peptidverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Also Published As

Publication number Publication date
GB2066262A (en) 1981-07-08
DK513480A (da) 1981-07-09
CA1151642A (en) 1983-08-09
PT72141A (en) 1981-01-01
IT1127930B (it) 1986-05-28
ES497353A0 (es) 1982-06-16
ES8300087A1 (es) 1982-10-01
DE3044793A1 (de) 1981-06-19
NO803640L (no) 1981-06-04
ES8205753A1 (es) 1982-06-16
GB2066262B (en) 1983-05-11
US4273704A (en) 1981-06-16
ES508060A0 (es) 1982-10-01
BE886472A (fr) 1981-06-03
NL8006586A (nl) 1981-07-01
JPS5692847A (en) 1981-07-27
SE8008428L (sv) 1981-06-04
PT72141B (en) 1981-10-28
AU6499080A (en) 1981-06-11
IT8050294A0 (it) 1980-12-02
FR2476073A1 (fr) 1981-08-21

Similar Documents

Publication Publication Date Title
ZA807513B (en) N-admantane-substituted tetra-peptide amides
GB2054586B (en) Antihypertensive amides
NZ193353A (en) Herbicidal -azolyloxyalkanoic acid amides
CS345184A2 (en) Zpusob pripravy n heterocyklyl 4 piperidinaminu
ZA785698B (en) Amides
CS270884A2 (en) Zpusob konstrukce replikovatelneho prostredku pro klonovani
CS510880A2 (en) Zarizeni pro injekcni strikacky
GB2042051B (en) Releasable fastening
JPS55118483A (en) 55alkyll22*44cyanophenyl**1*33dioxanes
DE3067021D1 (en) Improved gamma-sorbitol polymorph and uses thereof
IL67929A0 (en) Pyrroleacetic amides
JPS5636485A (en) 2*33dihydroo2*6*77trisubstitutedd55 acylbenzofuran
JPS5695198A (en) Ee55*22halogenovinyl**2**deoxycytidines
JPS5645478A (en) 5**aminoalkyll4**44dialkylpsoralen
JPS5645480A (en) 4**substitutedd4*5**88trialkylpsoralen
GB2058782B (en) Polyprenylcarboxylic acid amides
JPS5697276A (en) Alphaaaryll1hh1*2*44triazolee11ethanols
CS660880A2 (en) Zpusob vyroby 2 substituovanych 4 substituovanych kyselin 5 thiazolkarboxylovych
JPS5699475A (en) 11*88quinolyl**22pyrrolidinone
CS570580A2 (en) Zarizeni pro kontinualni chemicke zpracovani kapalin
GB8319141D0 (en) 2 6 6-trimethyl-cyclo-hex-3-en-1-one
CS60780A2 (en) Zpusob vyroby 4 amino 2 piperidinochinazolinovych derivatu
CS619580A2 (en) Pridrzne zarizeni pro nohu
CS670380A1 (en) Zarizeni pro vyrobu kapaliny pro pripravu roztoku
GB2063982B (en) Fastening